The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ICML 2019 | Follicular lymphoma: BR in the frontline and pre-treatment PET
Paolo Strati, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of BR vs. R-CHOP as an initial treatment for advanced follicular lymphoma (FL), and the prognostic value of a pre-treatment PET scan in FL patients receiving frontline therapy. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
